Action RMDA TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) S.A.E.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

Actions

RMDA

EGS381B1C015

Cours en clôture Egyptian Exchange
Autres places de cotation
 00:00:00 14/05/2024 		Varia. 5j. Varia. 1 janv.
1,99 EGP 0,00% Graphique intraday de Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. -4,78% +20,61%
14/05 Dixième jour du Ramadan pour les industries pharmaceutiques et les réactifs de diagnostic (Rameda) S.A.E. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
19/03 Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Reports Earnings Results for the Full Year Ended 31 December 2023 (en anglais seulement) CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E.(CASE:RMDA) dropped from EGX 30 Index
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Ekuity B.V. acquired additional 5.38% stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for approximately EGP 160 million.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. announces an Equity Buyback for 10% of its issued share capital.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. authorizes a buyback plan.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
The Saudi Seventh Investment Company agreed to acquire additional 6.5% stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for GGP 135 million.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda E : Pharmaceutical Industries & Diagnostic - Rameda (RMDA.CA) - Listing Committee Decision
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda E : Pharmaceutical Industries & Diagnostic - Rameda (RMDA.CA) Reports Year Ended 31/12/2021 Consolidated Results
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E.(CASE:RMDA) added to EGX 30 Index
Equinox Pharma Holding Ltd. acquired additional 2.71% minority stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for EGP 58.3 million.
STenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Announce Audited Consolidated Earnings Results for the Quarter Ended March 31, 2021
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action RMDA
  4. Actualités Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
  5. Autres langues